400
Participants
Start Date
January 31, 2012
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
Aspirin
325mg loading dose once on study day 1, followed by 81mg dose once daily on study days 2-7. Administered by mouth or down nasal gastric tube.
Lactose powder
Matching lactose powder filled capsules will be administered on days 1-7.
Montefiore Medical Center, The Bronx
Temple University School of Medicine, Philadelphia
Wake Forest University Medical Center, Winston-Salem
Duke University Medical Center, Durham
Mayo Clinic in Florida, Jacksonville
University of Florida, Gainsville
University of Louisville Medical Center, Louisville
University of Michigan, Ann Arbor
Mayo Clinic in Rochester, Rochester
University of Illinois at Chicago, Chicago
Stanford Univeristy, Stanford
Harborview Medical Center, Seattle
Bridgeport Hospital, Bridgeport
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Lead Sponsor
Beth Israel Deaconess Medical Center
OTHER
Montefiore Medical Center
OTHER
Vanderbilt University Medical Center
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
National Center for Research Resources (NCRR)
NIH
Mayo Clinic
OTHER